Andrew Davis, MD
Andrew Davis, MD, is an assistant professor in the Division of Oncology (Department of Medicine) at Washington University School of Medicine and specializes in breast cancer. Prior to coming to Washington University, he performed his medical school, residency, and hematology/oncology training at Northwestern University, where he served as a chief fellow during his final year.
He is the principal investigator or site principal investigator of multiple Phase I and Phase II clinical trials. Along with his interest in developing novel therapeutics for cancer patients, his research explores the role of liquid biopsies, including circulating tumor DNA, to detect disease recurrence, resistance, and stratification in novel clinical trial designs. In addition, he is also actively involved in education through the hematology/oncology fellowship program.
In his free time, he enjoys spending time with his children, travel, and watching Minnesota sports.